MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from public
offering, net of...
$172,960K
Cash in-transit for
stock option...
$5,162K
Proceeds from espp
$180K
Net cash provided by
financing activities
$178,302K
Net increase
(decrease) in cash, cash...
$41,788K
Canceled cashflow
$136,514K
Stock-based compensation
$58,863K
Depreciation
$18,328K
Accrued and other
current liabilities
$9,273K
Accounts payable
$8,070K
Amortization of operating
lease right-of-use...
$7,992K
Non-cash lease
impairment expense
$1,910K
Long-term deposit
$1,500K
Other assets
-$59K
Adjustment to reconcile net
income to cash provided...
$20K
Net cash provided by
(used in) operating...
-$136,008K
Net cash provided by
(used in) investing...
-$506K
Canceled cashflow
$106,015K
Net loss
-$229,967K
Purchase of property and
equipment
$506K
Operating lease liability
-$11,165K
Prepaid expenses and
other current assets
$891K
Back
Back
Cash Flow
source: myfinsight.com
Kodiak Sciences Inc. (KOD)
Kodiak Sciences Inc. (KOD)